Indiana Announces Equine Drug Testing Program for 2015
Edited Press Release
March 12, 2015
The program includes a new primary testing lab, an audit lab, expanded out-of-competition testing, and cobalt testing.
The program includes a new primary testing lab, an audit lab, expanded out-of-competition testing, and cobalt testing.
Issues include tax matters and racehorse drug and therapeutic medication regulation and testing.
David Howman will discuss the organization’s efforts in bringing international consistency to anti-doping policies.
The legislation would require the New Mexico Racing Commission to establish rules for handling drug testing specimens.
Study topics include laminitis, foal pneumonia, stem cells, endometritis, joint issues, insulin resistance, and more.
The event, which is open to the public, will be held March 16 at 5:30 p.m. in Ocala, Florida.
Regulators are paying close attention to this seemingly innocuous trace mineral found in B vitamins. Find out why.
Bone is a vital tissue that’s densely packed with specialized cells and supplied with a rich network of blood vessels.
North America Thoroughbred stakeholders respond to the British Horseracing Authority’s new Equine Anti-Doping Rules.
Legislation governing racehorse medication policy passed the Florida Senate Regulated Industries Committee Feb. 18.
Under the provision the official vet must observe a horse bleeding from one or both nostrils during or after the race.
Legislation governing equine medication policy is scheduled to be heard Feb. 18.
A number of samples from Thoroughbred racehorses recently came back positive for anabolic steroids.
The sales company will begin implementing guidelines for controlled therapeutic medications this spring.
Dr. Foster Northrop and Dr. Eric Mueller join a group working to pass pari-mutuel wagering legislation in Georgia.
Starlight issued the challenge in memory of Intense Holiday, a racehorse who was euthanized after developing laminitis.
Stay on top of the most recent Horse Health news with
